PharmacyCodes



Apo-Quinidine en es it fr

Apo-Quinidine Brand names, Apo-Quinidine Analogs

Apo-Quinidine Brand Names Mixture

  • No information avaliable

Apo-Quinidine Chemical_Formula

C20H24N2O2

Apo-Quinidine RX_link

http://www.rxlist.com/cgi/generic/quinidine.htm

Apo-Quinidine fda sheet

Apo-Quinidine FDA

Apo-Quinidine msds (material safety sheet)

Apo-Quinidine Synthesis Reference

No information avaliable

Apo-Quinidine Molecular Weight

324.417 g/mol

Apo-Quinidine Melting Point

174 oC

Apo-Quinidine H2O Solubility

140 mg/L

Apo-Quinidine State

Solid

Apo-Quinidine LogP

2.534

Apo-Quinidine Dosage Forms

Solution

Apo-Quinidine Indication

For the treatment of ventricular pre-excitation and cardiac dysrhythmias

Apo-Quinidine Pharmacology

Quinidine, a hydantoin anticonvulsant, is used alone or with phenobarbital or other anticonvulsants to manage tonic-clonic seizures, psychomotor seizures, neuropathic pain syndromes including diabetic neuropathy, digitalis-induced cardiac arrhythmias, and cardiac arrhythmias associated with QT-interval prolongation.

Apo-Quinidine Absorption

No information avaliable

Apo-Quinidine side effects and Toxicity

No information avaliable

Apo-Quinidine Patient Information

Before prescribing QUINAGLUTE® as prophylaxis against recurrence of atrial fibrillation, the physician should inform the patient of the risks and benefits to be expected. Discussion should include the facts

  • that the goal of therapy will be a reduction (probably not to zero) in the frequency of episodes of atrial fibrillation; and
  • that reduced frequency of fibrillatory episodes may be expected, if achieved, to bring symptomatic benefit; but
  • that no data are available to show that reduced frequency of fibrillatory episodes will reduce the risks of irreversible harm through stroke or death; and in fact
  • that such data as are available suggest that treatment with QUINAGLUTE® is likely to increase the patient's risk of death.

To confirm whether this is the most current prescribing information available on Quinaglute®, or to obtain the most current prescribing information, please call Berlex Laboratories at 1-888-BERLEX-4 (choose option #4, Product Usage Information).

Apo-Quinidine Organisms Affected

Humans and other mammals